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Background: Phyto-remedies for diabetic control are popular among patients with Type II Diabetes mellitus (DM),
in addition to other diabetic control measures. A number of plant species are known to possess diabetic control
properties. Costus pictus D. Don is popularly known as “Insulin Plant” in Southern India whose leaves have been
reported to increase insulin pools in blood plasma. Next Generation Sequencing is employed as a powerful tool for
identifying molecular signatures in the transcriptome related to physiological functions of plant tissues. We
sequenced the leaf transcriptome of C. pictus using Illumina reversible dye terminator sequencing technology and
used combination of bioinformatics tools for identifying transcripts related to anti-diabetic properties of C. pictus.
Results: A total of 55,006 transcripts were identified, of which 69.15% transcripts could be annotated. We identified
transcripts related to pathways of bixin biosynthesis and geraniol and geranial biosynthesis as major transcripts
from the class of isoprenoid secondary metabolites and validated the presence of putative norbixin
methyltransferase, a precursor of Bixin. The transcripts encoding these terpenoids are known to be Peroxisome
Proliferator-Activated Receptor (PPAR) agonists and anti-glycation agents. Sequential extraction and High
Performance Liquid Chromatography (HPLC) confirmed the presence of bixin in C. pictus methanolic extracts.
Another significant transcript identified in relation to anti-diabetic, anti-obesity and immuno-modulation is of
Abscisic Acid biosynthetic pathway. We also report many other transcripts for the biosynthesis of antitumor,
anti-oxidant and antimicrobial metabolites of C. pictus leaves.
Conclusion: Solid molecular signatures (transcripts related to bixin, abscisic acid, and geranial and geraniol
biosynthesis) for the anti-diabetic properties of C. pictus leaves and vital clues related to the other phytochemical
functions like antitumor, anti-oxidant, immuno-modulatory, anti-microbial and anti-malarial properties through the
secondary metabolite pathway annotations are reported. The data provided will be of immense help to researchers
working in the treatment of DM using herbal therapies.
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Diabetes mellitus (DM) is one of the most widely occur-
ring metabolic disorders throughout the world which is
characterized by chronic hyperglycemia as a result of in-
sulin resistance or defect in insulin secretion. Defects in
insulin secretion and/or action, results in increased
blood glucose levels and the condition is termed as DM.
Type 2 DM represents 90-95% of the cases and the indi-
viduals affected by this disorder generally have insulin
resistance and a relative insulin deficiency [1]. Even
though, there are several medicines available for diabetic
management, they are associated with significant side
effects that affect the quality of life. Herbal preparations
also play a vital role in diabetic management. Various
drug targets have been detailed for DM and the need for
systematic evaluation of herbal therapeutics at molecular
level has been urged to be included in medical practices
[2]. Intense molecular studies on herbal remedies and
the elucidation of their molecular mechanisms will bring
out a potentially powerful anti-diabetic therapy and will
be immensely beneficial to patients.
Many indigenous plants with different biochemical
properties have been reported to possess anti-diabetic
properties. Costus pictus D. Don (Figure 1) is one such
native plant of Mexico and was introduced to India in
recent years. It has gained increased popularity in re-
cent years due to its anti-diabetic properties and is
commonly called as “Insulin plant” or “Spiral Ginger”
[3]. The leaves of this plant have been reported to pos-
sess anti-diabetic properties [3-9]. A patent has been
filed: “Preparation process and a regenerative method
and technique for prevention, treatment and glycemic
control of diabetes mellitus using Costus pictus extract”
which describes that oral supplementation of C. pictus
(500–2000 mg) per day brings down the blood glucoseFigure 1 Costus pictus D. Don plant. A) A young C. pictus growing in polevels in diabetic patients [4]; however, no commercial
anti-diabetic product is available yet. Various hypotheses,
on the possible mechanisms responsible for the anti-
diabetic potential of the plant include i) suppression of
carbohydrate hydrolysing enzymes like α-amylase and α-
glucosidase [3], ii) stimulation of insulin secretory re-
sponse by increasing Ca2+ influx through voltage gated
Ca2+ channels [5], iii) β-amyrin as being the active and
responsible component [6], and iv) PTP1B inhibition
and IRβ–PI3K activation [8]. However, the exact mech-
anism of action of the leaves is still elusive. The anti-
diabetic properties of the leaves are strongly supported
by their anti-oxidant properties [9]. There have also been
reports on the leaves that they work against cancer [10].
The leaves are also suggested to act as anti-bacterial and
anti-glycation agents [9]. C. pictus is also known to be a
powerful diuretic agent which is used in treatment of
renal disorders [11].
Genomic analysis of C. pictus, a non-model medicinal
plant, is limited by the small quantity of publicly avail-
able sequence data. However, the emergence of next
generation sequencing has paved the way for large scale
sequencing of several non-model plants which can be
valuable in investigating the basis of medicinal proper-
ties of such plants. Different Next Generation Sequen-
cing (NGS) technologies and their potential applications
in plant biology including transcriptome investigations
have been reviewed [12]. Strategies and tools which can
be employed in transcriptome studies of non-model
plants using second generation sequencing have been
discussed [13]. Non-model plants that have been re-
cently sequenced include Daucus Cicer arietinum L.
[14], Carota var. sativus L. [15], Hevea brasiliensis [16],
Sesamum indicum L. [17], Ipomoea batatas [18], Camel-
lia sinensis [19], Acacia auriculiformis, Acacia mangiumt cultures B) A view of fully grown C. pictus at the flowering stage.
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Myrica rubra [23], and many others are in progress.
Even though many plant species are reported to be of
anti-diabetic importance, the only plant that was
reported to be sequenced is Gynostemma pentaphyllum
[24]. We have undertaken an NGS based approach to se-
quence the C. pictus transcriptome in order to identify
and characterize transcripts potentially contributing to
the observed medicinal properties. We have confirmed
the presence of a precursor to Bixin viz Putative nor-
bixin methyltransferase. This study will aid in the under-
standing of the therapeutic potential of C. pictus and
serve as a valuable resource for numerous researchers
working on developing treatments for DM. Availability
of this transcriptomic data in public domains will also
enable genome wide comparative studies of closely
related medicinal plants of anti-diabetic importance.Results
Sequencing and quality control
A total of 44 million, 73 base paired-end reads
(22,222,948 * 2 = 3.2Gb) were generated by the Illumina
Genome Analyzer IIx Sequencer. The raw paired-end se-
quence data in FASTQ format is deposited in the Na-
tional Centre for Biotechnology Information's (NCBI)
Short Read Archive (SRA) database under the accession
number SRA052634. Raw reads were subjected to qual-
ity control using SeqQC. High quality (>Q20) bases were
more than 97% in both the forward and the reverse
(paired-end) reads. Percentage of unresolved bases (Ns)
was observed to be very minimal (0.006% in forward
read and 0.149% in reverse read). The results alsoFigure 2 Transcript Assembly Information. A) Transcript Length Distribushowed that the average Phred scaled quality score (Q
score) was above 30 (>Q30) at all base positions in both
the reads indicating a very high quality sequencing run.
After processing adapter sequences and low quality
sequences from the raw data, 41,104,416 high quality
reads (~92.5% of total reads) were retained. These high
quality, processed paired-end reads were used to assem-
ble into contigs and further into transcripts.
De novo assembly
De novo assembly of the processed reads using Velvet
yielded 53,416 contigs. A k-mer of 47 resulted in an op-
timal assembly in comparison to other k-mer assemblies
based on different assembly quality parameters like N50
length, average contig length, total length of the contigs,
total number of contigs, longest contig length and num-
ber of Ns. The contigs were further assembled into tran-
scripts using the transcriptome assembly software,
Oases. Transcripts which were shorter than 200 bases in
length were filtered out, resulting in 55,006 transcripts.
The lengths of the assembled transcripts are represented
as a bar chart (Figure 2 A).
Number of unresolved bases (Ns) was found to be very
minimal (181 in number). Total length of the transcripts
was observed to be 48,190,783 bases (48.1 Mb) and aver-
age length of the transcripts was approximately 876
bases (Table 1). The transcripts were found to be mar-
ginally AT-rich - 55.4% (Figure 2 B).
N50 is a statistic widely used to assess the quality of
sequence assembly. Higher the N50 value better is the
assembly. The N50 in our assembly was found to be
1,353 bases, which was higher than most other plant
transcriptome assemblies published, barring a fewtion B) ATGC Composition of assembled transcripts.
Table 1 Assembly Statistics
Total Number of Transcripts 55,006
Maximum Transcript Length (in bases) 15,313
Minimum Transcript Length (in bases) 201
Average Transcript Length (in bases) 876.1
Total Transcripts Length (in bases) 48,190,783
Total Number of Ns 181
Transcripts > 500 b 29,835
Transcripts > 1 Kb 16,210
Transcripts > 10 Kb 9
N50 size (in bases) 1,353
GC % 44.6
AT % 55.4
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quences are deposited at NCBI's Transcriptome Shotgun
Assembly (TSA) sequence database and are assigned
GenBank accession numbers (JW214778-JW269783).
Functional annotation
Functional annotation of novel plant transcriptomes is a
challenging task due to the limited availability of refer-
ence genome/gene sequences in public databases. Being
a non-model plant and without much availability of
reference sequences in the databases, it is challenging to
predict accurate annotations for the transcripts. In order
to maximise annotation percentages, six different data-
bases (PlantCyc, UniProt: Swiss-Prot, UniProt: TrEMBL,
Cluster of Orthologous Groups, Pfam and Viridiplantae
mRNA), were mined. This strategy resulted in 69.15% of
the transcripts being annotated. Although the TrEMBL
database and the all Viridiplantae mRNA database from
GenBank lacked proper annotation, they were included
to increase the possibility of annotating the unknown
transcripts which do not have significant similarity in
well annotated databases. A six-way venn diagram was
constructed to depict the sharing of transcripts anno-
tated by the six databases (Additional file 1).Table 2 Comparison of N50 values with other plant
transcriptome assemblies
Organism N50 (in bases)
Cicer arietinum L. [14] 1192
Daucus carota var. sativus L. [15] 1378
Hevea brasiliensis [16] 485
Sesamum indicum L. (3 libraries) [17] 220, 150, 180
Ipomoea batatas [18] 765
Camellia sinensis [19] 506
Acacia auriculiformis [20] 948
Acacia mangium [20] 938
Cajanus cajan L. [21] ~1500
Euphorbia fischeriana [22] 1510Pathway annotation
Pathways possibly contributing to anti-diabetic, anti-oxi-
dant, antimicrobial, anti-glycation and antitumor proper-
ties of C. pictus leaves reported earlier [3-10] were
studied. The PlantCyc database was used to annotate
5,512 transcripts and was vital in retrieving pathways
specifically from plants. Terpenoids, also called isopre-
noids, are a large group of secondary metabolites which
are reported to function in communication and defense,
as antitumor, as anti-malarial and as anti-diabetic agents
[25]. We focused on studying terpenoid pathways along
with other secondary metabolite pathways (Additional
file 2) to identify clues related to the medicinal proper-
ties of the plant with the help of PlantCyc annotations.
The observed terpenoid pathways are represented in a
pie-chart (Figure 3). A major share of the transcripts
related to terpenoid pathways was noticed to be from
bixin biosynthesis (10.49%) and geraniol and geraniol
biosynthesis (8.95%) pathways which have been impli-
cated with anti-diabetic functions [26,27]. Abscisic Acid
(ABA) biosynthesis (3.09%) transcripts observed are also
reported to have anti-diabetic functions [28,29]. Anti-
oxidant properties have been reported in some of the
by-products from the annotated pathways which include
bixin [30], astaxanthene, canthaxanthene [31], all-trans-
lycopene, lutein [32], crocetin [33], gossypol [34], sapo-
nins [35], oleoresin [36] and this correlates with the
strong anti-oxidant properties of C. pictus. Transcripts
corresponding to Menthol biosynthetic pathway were
also found to occur predominantly (8.02%); the end-
product menthol might contribute to the antitumor
proeprties [37]. The other by-products from the anno-
tated pathways which could potentially render the anti-
tumor properties include taxol [38], all-trans-lycopene
[39], geraniol [40], bixin [26], astaxanthene [31], crocetin
[33], gossypol [34], vincristine and vinblastine [41] and
perillyl alcohol [42]. Transcripts, corresponding to
mevalonate pathway I, were observed to be in 4.94% of
the transcripts annotated for terpenoid pathway. Isopen-
tyl diphosphate (IPP) and its isomer dimethylallyl di-
phosphate (DMAPP), the end-products of mevalonate
pathway, are the universal precursors of the terpenoid
category [25]. Transcripts related to artemisinin biosyn-
thetic pathway were also observed in pathway annota-
tions; artemisinin, the end-product of the pathway is a
proven anti-malarial agent [43]. The annotations of tran-
scripts relating to biosynthetic pathways of linalool, far-
nesene, bergamotene, capsidiol, gossypol, saponins,
oleoresin, isopimaric acid, phytoalexins and sesquiterpe-
noid phytoalexins suggest that they might provide the
plant with either anti-microbial or insect/herbivore
defense. The other transcript annotations related to bio-
synthetic pathways include those of phaesic acid, palu-
notol, gibberelins and fenchol.
Figure 3 Percentage distribution of terpenoid pathway related transcripts observed from PlantCyc enzymes annotation.
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ways also provide us information about certain phyto-
chemicals (Additional file 3). 4-coumarate-CoA ligase
transcripts, which were predominantly observed, are
intermediates in a lot of metabolic pathways, indicat-
ing their pivotal roles in plant metabolism. A major
chunk of the flavonoid biosynthetic pathway transcripts
(36.56%) was contributed by transcripts annotated as 4-
coumarate-CoA ligase. Transcript annotations from
scopoletin biosynthesis (16.49%) were also found to
occur. Scopoletin is known to be involved in plant
defense mechanisms [44]. Myricetin, an intermediary
metabolite from the observed syringetin biosynthetic
pathway, is known to possess anti-oxidative and anti-
diabetic properties [45]. Transcript annotations related
to anthocyanin metabolism (known for coloration) in-
clude rose anthocyanin, shisonin, pelargonidin, and
gentiodelphin. Leucopelargonidin and leucocyanidin bio-
synthetic pathway, precursor to leucodelphinidin biosyn-
thesis, was also noticed in the annotations. We also
observed transcripts corresponding to chalcone 2'-O-
glucosyltransferase and aurone which are known for
providing yellow coloration. Antitumor properties might
also have been obtained from the observed coumarin
[46] and quercetin [47] biosynthetic pathways. Insect re-
sistance could have also been rendered by the presence
of glycosyl transferases, pinobanksin and glyceollin bio-
synthetic pathways. Other general pathways to which the
transcripts showed similarity include flavonol biosyn-
thesis I, isoflavonoid biosynthesis I and II.
Gene ontology (GO) annotation
The Swiss-Prot database annotation covered 38.25% of
the transcripts and GO terms were derived based on the
annotation information (Additional file 4). The three
categories of GO Cellular component, Molecularfunction and Biological Process were represented by
27,871, 38,886 and 31,671 terms respectively (Figure 4).
In the Biological Process category, classes related to
DNA-dependent transcription (6.1%) and DNA-dependent
regulation of transcription (4.2%) were observed to be oc-
curring most frequently. Defense response was represented
in many a number of pathways from pathway annotations.
C. pictus is commonly known for its insect resistance
properties and is a common factor in herbal plants, which
was reflected in the occurrence of defense response among
the top Biological Process category. In the Molecular
Function category, ATP binding (11.02%) was found to be
the most abundant class. The most frequently occurring
GO terms within Cellular Components include integral to
membrane (17.1%), nucleus (13.05%) and plasma mem-
brane (9.4%).
KOG annotation
The eukaryotic clusters (KOGs) present in the Cluster
of Orthologous Groups (COG) database are made up
of protein sequences from Arabidopsis thaliana, Cae-
norhabditis elegans, Drosophila melanogaster, Homo
sapiens, Saccharomyces cerevisiae, Schizosaccharomyces
pombe and Encephalitozoon cuniculi. The KOG pro-
teins from the eukaryotic clusters were used to anno-
tate 24,424 transcripts and with the help of the
annotations, we were able to assign KOG terms to
each annotation (Additional file 5). The KOG classifi-
cations with multiple assignments were individually
assessed and assigned to transcripts (Figure 5).
Cellular Processes and Signalling (31.16%) was found
to be the major category from the KOG classifications,
of which Signal transduction mechanisms were found
to be prominent (11.07% of the total KOG classifica-
tions) followed by Post translational modification, pro-
tein turnover, chaperones (9.87%) and Intracellular
Figure 4 GO Classification. GO terms were derived based on the similarity search with Swiss-Prot database. The top 10 GO terms in Cellular
Component, Molecular Function and Biological Process are displayed.
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the Information Storage and Processing category, Tran-
scription (5.49%), Translation, ribosomal structure and
biogenesis (4.65%) and RNA processing and modification
(4.22%) were observed to be highly occurring. In the
metabolism category, the frequently observed classes
were Carbohydrate transport and metabolism (4.82%),
Lipid transport and metabolism (4.24%), Amino acid
transport and metabolism (4.13%), Energy production
and conversion (3.7%). Our focus on the secondaryFigure 5 KOG Functional Classification. 44.4% (24,424) of the transcripts
functional categories.metabolite transcripts and a fair representation of Sec-
ondary metabolites biosynthesis, transport and catabol-
ism transcripts in KOG classification (3.2%) further
attests the data integrity both at sequencing as well as
analysis levels. From the poor characterized annota-
tions, General function prediction only represented
18.02% and Function unknown represented 5.62%,
which is quite expected since C. pictus is remotely
similar to the organisms originally present in the
eukaryotic KOG database.were annotated against the KOG proteins and were assigned KOG
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Using InterProScan, 25,973 transcripts were annotated
against Pfam domains (Additional file 6) and the highly
occurring Pfam domains were plotted as a bar chart
(Figure 6). The aim of this approach was to identify
similarity at domain level, where the proteins have little
similarity at sequence level but might share conserved
structural domains.
Protein Kinase (Pkinase) domain along with Protein
Tyrosine Kinase (Pkinase_Tyr) domain were represented
the most in transcripts indicating strong signal transduc-
tion mechanisms. WD40 repeat domains which also
have significance in signal transduction mechanisms
were also observed. Myb domain (Myb_DNA-binding)
annotations, significant for being transcription factors
with a wide range of functions, were observed in Pfam
transcript annotations and corresponded to the obser-
vance of a lot of Myb class proteins from Swiss-Prot
annotations: MY1R1, MYB06, MYB08, MYB1, MYB2,
MYB32, MYB38, MYB4, MYB44, MYB5, MYB86,
MYBA1, MYBC, MYBF and MYBP. The other fre-
quently occurring domain was Cytochrome P450 (p450)
which mediates oxidation of organic substances. RNA
recognition motif (RRM_1), Pentatricopeptide repeats
(PPR_2), Mn++ or Mg++ dependent protein serine/
threonine phosphatase domains (PP2C), Mitochondrial
carrier domains (Mito_carr) and Zinc-finger related
RING protein domains (zf-RING_2) were also highly
represented in transcript annotations.
Final annotation table
Even though individual database annotations were used
to interpret findings, a final annotation table was
obtained in order to arrive at a single best annotationFigure 6 Top 10 Pfam domains represented in InterProScan transcrip
InterProScan and the top 10 domain annotations were represented in thefor each transcript. After deriving the best annotation
for each transcript from multiple databases (Additional
file 7), the final annotations comprised 17,482 (31.78%)
transcripts from Swiss-Prot database, 1,041 (1.89%) tran-
scripts from PlantCyc database, 11,768 (21.39%) tran-
scripts from KOG proteins database, 7,243 (13.16%)
transcripts from TrEMBL database, 317 (0.58%) tran-
scripts from GenBank Viridiplantae nucleotide sequences
and 188 (0.34%) transcripts from Pfam database (Table 3).
TrEMBL initially had the highest share of annotations.
However, in the final annotation table, major shares of
the results were distributed among the well annotated
databases (Swiss-Prot and KOG).
We observe that some of the transcript annotations
were represented as predicted or hypothetical. The fol-
lowing terms were found in the annotation: Probable
(2,071, 3.76%), Putative (679, 1.23%), Unknown (18,
0.03%), Hypothetical (13, 0.02%) and Predicted (1,550,
2.81%). However, the number of such instances is very
less, considering that it is a non-model plant from Cost-
aceae family.
Mapping reads, calling variations and quantification of
transcripts
Alignment statistics were reported from the SAM format
alignment files using custom Perl codes (Table 4).
Large number of the reads (91%) aligned back to the
transcripts as expected (Table 4). Due to low expression
of certain transcripts, the reads belonging to them might
be either partially assembled or left out completely dur-
ing the assembly process. This leads to a small fraction
of reads unused during the assembly process. In our
case, 9% of the reads did not align back to the transcript
reference sequences. Post-processing the SAM file usingt annotations. Pfam Domain annotations were obtained from
chart.
















Figure 7 Expression profile of the transcripts. The colors ranging
from red to green indicate the expression levels from high to low.
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SNPs (Additional file 8).
An expression profile of the transcripts was created
using Agilent's GeneSpring (Figure 7). The transcript
with the highest expression levels from the annotation
was found to be a Cell wall hydroxyproline-rich glycopro-
tein (Extensin). The other protein annotations which
were part of the top 10 highly expressed transcripts in-
clude isoforms from Ribulose bisphosphate carboxylase
small chain (Chloroplastic), Polyubiquitin 4, isoforms of
Chlorophyll a-b binding protein (Chloroplastic), Photo-
system I reaction center subunit V (Chloroplastic) and
FOG Zinc Finger proteins. There was a putative protein
as well among the top 10 highly expressed transcripts.
Most of the highly expressed transcripts belong to the
class of housekeeping genes. The transcripts which
showed lower expressions belonged to either uncharac-
terized or probable (predicted) class of proteins. How-
ever, there was one transcript which showed match to
Auxin response factor 1 from the low expressed
transcripts.
Validation of assembled transcripts
Validation of the assembled transcripts was performed
for two high copy genes viz Ribulose bi phosphate Ribu-
lose-1,5-bisphosphate carboxylase and an unnannotaed
transcript and two genes of biological significance viz.
Putative norbixin methyltransferase and Lycopene cleav-
age oxygenase (Bixa orellana). All genes gave amplicons




% Reads Aligned 90.96
Reference Sequence Length (in bases) 48,190,986
Total Reference covered (in bases) 47,955,274
% Total Reference covered 99.51
Average Read Depth 54.57oxygenease which was not detected by transcript assem-
bly was also not detected by RTPCR using primers from
a related species for the same gene (See Supplementary
data Additional file 9).
SSR identification
Short Sequence Repeats (SSRs) are short repeat
sequences of 2–6 bases which are important molecular
markers in a wide range of genetics and genomics appli-
cations. A total of 8,482 SSRs were identified in 7,049
transcripts (Additional file 10). More than one SSR was
found to be in 1,126 transcripts. Compound SSRs were
observed to be 623 in number. Trinucleotide SSRs were
the most abundant accommodating 40.27% of the identi-
fied SSRs, followed by tetranucleotides (14.89%) and
dinucleotides (10.9%) (Table 5).
Similarity-search among other anti-diabetic plant
resources
After filtering the BLAST results using cut-offs men-
tioned in the methods, 13 out of 18 sequences from C.
pictus were represented in the assembled transcripts.
Four tRNA partial sequences and a RPB2 partial gene
Figure 8 Validation of assembled transcripts.
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also showed that C. pictus is more similar to Costus spe-
ciosus, another plant with anti-diabetic properties from
the same genus (Additional file 11).
HPLC analysis
High Performance Liquid Chromatography (HPLC) was
used to confirm the presence of Bixin in C. pictus
methanolic extract. UV-visible absorption spectrum of
both standard bixin and the leaf extract was recorded at
444 nm. The chromatograms of the standard bixin and
C. pictus methanolic extract recorded peaks correspond-
ing to bixin (Figure 9).
Discussion
Transcriptome wide studies on a variety of organisms
have recently been conducted on a large scale, following
the revolution introduced by the emergence of Next
Generation Sequencers. Whole transcriptome sequen-
cing using an Illumina GAIIx sequencer and analysis of
the C. pictus plant leaves were reported for the first time
in this study, in order to understand molecular signa-
tures related to the anti-diabetic principles. We obtained
about 3.2 Gb of raw sequence data, which was processedTable 5 Identification of SSRs using MISA





6 440and de novo assembled into contigs and further into
transcripts. De novo assemblies are highly dependent on
k-mer lengths. In general, plant assemblies are very hard
and difficult owing to the complex gene contents, higher
ploidy, higher rates of repeats and heterozygosity [48].
Longer k-mers are advantageous in distinguishing
repeats from real overlaps [49] and are accurate, and in
general suit the assembly of highly expressed transcripts
[50] while shorter k-mers are preferred for assembly of
low expression genes. To balance between higher accur-
acy from longer k-mers and better assemblies for low
expressed genes from short k-mers, we ran multiple as-
semblies to arrive at an optimal k-mer length for a better
assembly. Specific care was taken to remove adapters
and low quality sequences from reads, such that a high
quality assembly is obtained (Table 1). The N50 value of
the assembled data was comparable to other plant tran-
scriptome assemblies indicating a high quality assembly
(Table 2).
The complete and accurate transcriptome assembly of
plants is difficult and is limited to the currently available
de novo assembly tools. Hence, in our study, a single
transcript might be present redundantly as multiple iso-
forms or in multiple fractions and some of the tran-
scripts might have been lost during the assembly due to
low coverage. For instance, 4-coumarate-CoA ligase is
present redundantly in multiple copies, whereas tran-
scripts encoding lycopene cleavage dioxygenase - an im-
portant component of the bixin biosynthetic pathway
were not observed at all. Nonetheless, once newer effi-
cient assembly tools with improved algorithms are devel-
oped in the future, the publicly available raw data can be
re-used to create a better transcriptome assembly. The
attempt was made to not only computationally
characterize the transcriptome, but also to derive mo-
lecular clues to the medicinal properties of the plant.
We were successful in establishing a relationship of the
anti-diabetic property with the genetic makeup. Inter-
preting high-throughput data is a challenging aspect and
we have suggested ways to analyse and interpret a plant
transcriptome. It has been estimated that 15 to 25% of
the plant genome specifies pathways of natural product
biosynthesis [51]. The high number of transcripts that
have been annotated as secondary metabolite profiles
from C. pictus is a clear indication of the genetic com-
plexity of the species.
Our primary focus has been to understand the tran-
scripts involved in biosynthesis of the anti-diabetic prin-
ciples. The surprising presence of high number of
transcripts corresponding to bixin, norbixin and geraniol
indicate possible involvement of these active constitu-
ents in the plant's anti-diabetic activities (Figure 3). The
presence of the transcript for Putative norbixin methyl-
transferase further confirms these findings (Figure 8).
Figure 9 Chromatograms from HPLC. A) Chromatogram of standard bixin along with UV-visible absorption spectrum in the eluting solvent
(inset). B) Chromatogram of C. pictus methanolic extract along with UV-visible absorption spectrum in the eluting solvent (inset).
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http://www.biomedcentral.com/1471-2164/13/663Bixia orellana (Annato) is currently reported to be the
sole source of the natural pigment bixin [52], but our
findings on the presence of significant levels of bixin in
C. pictus leaves suggests that the leaves could be used as
an alternative source of Bixin for commercial supply.
Bixin and norbixin from Annato has been indicated to
activate Peroxisome Proliferator-Activated Receptor α
(PPARα), which in turn stimulates adipocyte differenti-
ation and increases the insulin dependent glucose uptake
in differentiated 3T3-L1 adipocytes [26]. The identifica-
tion of bixin synthase transcripts from our current anno-
tations was corroborated from results suggesting
presence of bixin from HPLC (Figure 9). Geraniol acti-
vates both PPARγ and PPARα thereby improving hyper-
lipidemia and glucose uptake [27]. ABA is another
notable terpenoid observed in our transcript annotations
which has anti-diabetic, anti-inflammatory, anti-obesity
and immuno-modulatory properties. ABA was observed
to be an endogenous stimulator of insulin release from
human pancreatic islets [28]. ABA is also known to sig-
nificantly increase the expression of PPAR and its asso-
ciated genes CD36 and aP2 [29]. An earlier report states
that the administration of aqueous extract of C. pictus
leaves in rats have significantly reduced the levels of tri-
glycerides and cholesterol, along with reduction in glu-
cose [7]. Purified methyl tetracosanoate from C. pictus
treatments in cells at 18 hours exhibited PPARα expres-
sion equivalent to rosiglitazone (50 lM) and the metha-
nolic extracts exhibited anti-diabetic activity as well asanti-adipogenic activity [8]. It is possible that the reduc-
tion in the levels of glucose, triglycerides and cholesterol
might have occurred through the activation of both
PPARγ and PPARα pathways by ABA, bixin, norbixin or
geraniol. These terpenoids might act as insulin sensiti-
zers in a way similar to thiazolidinedione drugs. Ginger
(Zingiber officinalis), a taxonomically closely related spe-
cies, is shown to be effective against the development of
cataract, a diabetic complication, in rats through its anti-
glycating potential [53]. C. pictus is also reported to be
an anti-glycation agent [9], which might be due of the
presence of geraniol and farnesene derivatives (geranyl-
geranyl, farnesylacetone, geranylgeranyl octadecanoato,
geranylgeranyl formiate and geranylgeranyl acetate)
which were observed to inhibit glycation and Advanced
Glycation End-product (AGE) formation [52], thereby
inhibiting certain diabetic complications. Aldose reduc-
tase, an enzyme of polyol pathway, is involved in diabetic
complications and docking studies show that citral (a
mixture of geraniol, geranial and neral) as well as gera-
niol inhibit aldose reductase activity [54]. The frontline
anti-diabetic drug “Metformin” also known as
“Dimethylbiguanide” was developed from a plant based
molecule from Galega officinalis. Current leads reported
for the first time from C. pictus might also emerge as a
powerful anti-diabetic and anti-glycation agents, if
researched further. Validation at the biochemical, cellu-
lar and pharmacological levels will supplement the tran-
scriptomic observations.
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http://www.biomedcentral.com/1471-2164/13/663Reactive Oxygen Species (ROS) are beneficial to the
organism and they are involved in signalling pathways
and are also toxic to pathogens [55]. But an increase in
ROS may be observed in many metabolic disorders and
are harmful. Oxidative stress and an increase in ROS are
common events accompanied with type II DM. In fact,
ROS have been shown to have a casual role in insulin re-
sistance and a decrease in ROS suppressed the insulin
resistance activity [56]. Hence, it is common to note that
most anti-diabetic herbal remedies are also potential
anti-oxidants. The anti-oxidant properties of C. pictus
have already been reported [9]. ROS may have potential
role in either cell proliferation or cell death which is
dependent on the intensity/location of oxidative burst
and also the anti-oxidant activities. In cancer cells, an
increased constitutive oxidative stress supports tumor
growth and protects the tumor from pro-apoptotic sig-
nals promoting tumor progression [55]. A reduction in
oxidative stress leads to suppressing tumors. C. pictus is
also shown to have anti-oxidant as well as antitumor
properties [10]. A number of secondary metabolites were
reported in this study which corresponded to anti-
oxidant and antitumor properties of C. pictus leaves.
Compounds classified as anti-oxidants generally reduce
the oxidative stress, but under certain conditions
they act as pro-oxidants. For instance, under non-
physiological conditions, although norbixin, a precursor
of Bixin was able to protect DNA from damage by ROS,
it might also create circumstances that amplify damaging
oxidative signal, unless some other anti-oxidant comes
to the defence [57]. This leads us to suggest that a single
isolated compound might not have the desired effect
and might also turn out to be toxic while promoting
DNA damage as a pro-oxidant. Hence, a combination of
plant compounds at optimal dosage is probably neces-
sary for a beneficial effect on a system.
C. pictus plants are known for their excellent insect re-
sistance potentials. They are also reported to have anti-
microbial properties [9]. The same is supported by the
secondary metabolite pathway annotations. It should be
noted that secondary metabolites from plants are gener-
ally expressed in minimal quantities by the plants, in
contrast to the expression of primary metabolites. The
fragmentation of the mRNAs during library preparation
could lead to the potential loss of whole or part of some
important genes, if their expression is very low. Low ex-
pression also means that considerable sequence coverage
will not be available and the fragmented sequences
might not be assembled into complete transcripts.
Hence, we chose to include any pathway hit in the anno-
tation, even if only fewer enzymes were captured in se-
quencing. For instance, lycopene cleavage dioxygenase
which converts lycopene to bixin aldehyde was cloned in
Escherichia coli and it subsequently activated bixinbiosynthetic pathway [51]. In our study, we did not ob-
serve transcripts corresponding to lycopene cleavage
dioxygenase enzyme, whereas transcripts corresponding
to the other two enzymes bixin aldehyde dehydrogenase
and norbixin carboxyl methyltransferase were observed.
One possibility could be that the transcript was not
expressed at adequate levels and might have been lost
during the de novo assembly or during cDNA fragmen-
tation before sequencing. The other possibility might be
the presence of an alternate precursor for bixin biosyn-
thesis. At this level, we could only attribute these rea-
sons for the missing transcripts. Critical annotations
from GO (Figure 4) and KOG (Figure 5) supported evi-
dences of signal transduction mechanisms, resistance
properties, DNA binding functions and defense mechan-
isms. Pfam annotations (Figure 6) abounded with Pro-
tein kinase domains. There is evidence that C. pictus
initiates an insulin secretory response by increasing Ca2+
influx through VGCC in mouse and human islets cell
cultures [5]. In human granulocytes, ABA has been
shown to bind to plasma membrane through a pertussis
toxin (PTX)-sensitive receptor-G protein complex,
which leads to an increase in cAMP, activation of pro-
tein kinase, phosphorylation of the ADPRC CD38 with
cADPR overproduction, eventually leading to an increase
of the Ca2+ [29]. The presence of ABA biosynthesis tran-
scripts (Figure 3) in the present study involving pathway
annotations could be functionally correlated with the
anti-diabetic activity of C. pictus possibly through activa-
tion of protein kinases.
The expression study gives us some clues about the
assembly. The transcripts with least expression values
could either be novel genes of interest with very low
copy numbers or they could be mis-assemblies which
did not find any similarity with the sequence databases.
Apart from just annotating the data, we have also
mined the data for other information like SNPs and
SSRs which will be invaluable, especially because C.
pictus is a non-model plant without genome sequences
being available. The reported SNPs and SSRs could be
used as molecular markers for the construction of gen-
etic linkage maps in the future. Substantial quantities
of oxalate content and oxalate oxidase activity were
reported in fresh leaf extracts [58]. The annotation
results, however, did not pick up oxalate oxidase or
oxaloacetate acetylhydrolase (enzyme involved in con-
version of oxaloacetate to oxalate) in our transcripts.
Our analysis indicates only the presence of malate de-
hydrogenase, the enzyme involved in the conversion of
malate to oxaloacetate.
Conclusions
We are reporting for the first time, solid molecular
signatures (transcripts related to bixin, ABA, and
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http://www.biomedcentral.com/1471-2164/13/663geranial and geraniol biosynthesis) for the anti-diabetic
properties of C. pictus leaves and are also providing
vital clues related to the other phytochemical functions
like antitumor, anti-oxidant, immuno-modulatory, anti-
microbial and anti-malarial properties through the sec-
ondary metabolite pathway annotations. Further, an
analytical proof of presence of bixin in C. pictus leaves
is provided through HPLC. We believe that this data
will be of immense help to researchers working in the
treatment of DM using herbal therapies. Even though
our focus was on transcripts relating to anti-diabetic
principles, we have limited clues about the role of sev-
eral other transcripts with no assigned function as of
now. They may modulate an anti-diabetic role in con-
junction with the major metabolites or conversely, they
may exert adverse reactions at cellular level. Advocat-
ing whole leaf consumption to diabetic patients may
not be advisable considering the phytochemical com-
plexity, as indicated by the transcriptome profile.
Hence, a thorough clinical research of the biochemical
and physiological properties of C. pictus leaf extracts
may be warranted before recommending it for large
scale usage by hyperglycemic individuals.
Methods
Sample collection and preparation
Fresh C. pictus leaves (fifth leaf from the bud) were col-
lected from a domestic garden of one of the authors
from Bangalore, India and brought to the laboratory in
ice. RNA was extracted from the leaf sample frozen in li-
quid nitrogen, using Agilent Plant RNA isolation mini
kit (Product No; 5188–2780) and was quantified using
Nanodrop. QC was performed using Agilent's Bioanaly-
zer. RNA Integrity Number (RIN) was observed to be
8.2. Transcriptome library for sequencing was con-
structed as outlined in Illumina's “TruSeq RNA Sample
Preparation Guide v2”.
Sequencing and quality control
Illumina GAIIx was used to generate 73 base paired-
end short reads using Sequencing By Synthesis (SBS).
Software including Real Time Analysis (RTA), Consen-
sus Assessment of Sequence and Variation (CASAVA)
and Off-Line Basecaller (OLB) from Illumina standard
pipeline was used to generate short read information
in FASTQ format (http://www.illumina.com/support/
sequencing/sequencing_software.ilmn). Additional qual-
ity control was performed using SeqQC V2.1 (http://
genotypic.co.in/SeqQC.html). Accuracy of base calling is
reflected in the quality scores and low quality scores usu-
ally denote high error probabilities. Low quality bases, if
due to errors, will interfere in the assembly process either
resulting in mis-assemblies by collapsing repeat regions
or fragmentation of contigs by obscuring true overlaps[49]. Hence, quality filtering is very essential in order to
arrive at a high quality assembly. The adapters, B tails
(CASAVA1.7 User Guide), and other low quality bases
were filtered or trimmed using in-house Perl scripts.
Thus filtered, high quality reads were used for further
analysis.
De novo assembly
De novo assembly of reads into contigs was performed
using De-brujin graph based assembler Velvet 1.1.07 –
http://www.ebi.ac.uk/~zerbino/velvet/ [49]. Parameters
like observed insert length and expected coverage were
estimated using an initial draft assembly. The final as-
sembly was generated with the parameters: k-mer as 47,
insert length as 154 +/− 51.6, expected coverage as 5
and coverage cut-off as 'auto'. The contig assembly was
followed by a transcriptome assembly with default para-
meters using Oases 0.2.01 - http://www.ebi.ac.uk/~zerbino/
oases/ [50]. Transcripts with at least 200 bases were con-
sidered for further analysis. In-house Perl scripts were
used to compute assembly statistics to assess the quality
of assembly.
Functional annotation
Annotation of novel transcriptomes is a challenging task,
hence, various databases were chosen to extract the
maximum possible information based on sequence and
functional similarity. The information collected include
Plant Pathway information (PlantCyc Enzymes database
v2.0 (www.plantcyc.org)), protein level sequence similar-
ity information (UniProt: Swiss-Prot and TrEMBL data-
bases downloaded as of 21st March 2012 [59]),
nucleotide level sequence information (Viridiplantae
mRNA database from GenBank downloaded as of 14th
March 2012), Clusters of Orthologous Groups (COG)
functional classifications (KOG proteins from COG
database downloaded as of 9th April 2012 [60]), and in-
formation on protein domains for distantly related pro-
teins which do not have similarity at sequence level
(Pfam database v26.0 [61]).
Similarity search was performed using locally installed
BLAST+ v2.2.25 software [62]. The transcripts were sub-
jected to similarity search against protein and nucleotide
sequence databases using blastx and megablast respect-
ively at an e-value cut-off of e-5. BLAST annotations
were filtered using either subject or query coverage
(>30%) and sequence identity (>50% for megablast and
identity >30% for blastx). Terpenoids along with other
secondary metabolites are known to be involved in a
number of therapeutic remedies; hence these metabolites
were critically examined from the annotations. Inter-
ProScan v4.8 - http://www.ebi.ac.uk/Tools/pfa/iprscan/
[63] was used to identify possible protein domains in the
transcripts.
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Primers were designed spanning ~200 bases or more of
the assembled transcripts (See supplementary data). 1 ug
of total RNA from C. pictus was converted to cDNA
using Affinityscript Reverse Transcriptase from Agilent
Technologies by using Oligo dT primers. cDNA was dis-
solved in 50 ul nuclease-free water and 2 ul was used as
template for each qRT-PCR reaction. qRT-PCR for each
primer pair was carried out in duplicates on an Agilent
technologies Stratagene Max3005p Real time PCR ma-
chine using the following conditions.
95C for 10 mins, ( 95C for 30sec, 55C for 1min, 72C
for 1min) for 40 cycles followed by 72C for 2mins for
final extension. Dissociation curves were generated using
95C for 1min 55C for 30 sec and 95C for 30sec.
Final annotation table
To obtain a final annotation table, the annotations from
each database were analysed using the BLAST scoring
system [62] to obtain the best annotation for each tran-
script. The order of preference for obtaining the best an-
notation was Swiss-Prot > PlantCyc > KOG. In case,
annotation information is unavailable from these three
databases, then information from TrEMBL or GenBank
Viridiplantae Nucleotide database annotations was used.
Pfam domain annotation was assigned, if the transcript
was not similar to either protein or nucleotide databases.
Mapping reads, calling variations and quantification of
transcripts
Due to lack of availability of a reference sequence, the
assembled transcripts were assumed to be the reference
sequence to compute transcript expression levels
[20,22,23]. The expression values were used to create an
expression profile with the help of Agilent's GeneSpring.
The read sequences were aligned against these transcript
reference sequences using Bowtie2 v2.0.0-beta5 - http://
bowtie-bio.sourceforge.net/bowtie2/index.shtml [64] in
end-to-end alignment mode. The alignments were pro-
cessed for further analysis like variant calling using
SAMtools v0.1.7a - http://samtools.sourceforge.net/ [65].
A combination of reads showing variation and read
depth, along with mapping quality and SNP quality were
considered for filtering the SNPs (Additional file 12). In-
house Perl scripts were used to compute the alignment
statistics. The expression levels of the transcripts were
estimated using Reads Per Kb per Million reads (RPKM)
normalized measure [66].
SSR identification
MISA (MIcroSAtellite identification tool - http://pgrc.
ipk-gatersleben.de/misa/) was used to identify SSRs. Di-
nucleotide and Trinucleotide repeats were given a mini-
mum threshold of 6 and 4 repeats respectively. Tetra,Penta and Hexanucleotide repeats were given a mini-
mum threshold of 3 repeats. The maximum distance be-
tween two SSRs was specified as 100 bases.Similarity-search among other anti-diabetic plant
resources
The transcripts were compared with known anti-diabetic
plant sequence resources which are found to have little se-
quence information. Nucleotide sequences of Costus spe-
ciosus (29), Syzygium cumini (15), Zingiber officinale (199),
Vaccinium myrtillus (34), Panax quinquefolius (237), Ros-
marinus officinalis (59), Momordica charantia (194),
Gynostemma pentaphyllum (95), Trigonella foenum-
graecum (47) and also C. pictus (18) were downloaded
from NCBI GenBank database. Pairwise alignments of
C. pictus transcripts using megablast against these plant
species were performed to observe similarity.HPLC measurements
HPLC analysis of the methanolic leaf extracts of C. pic-
tus was performed with L-4000 UV detector, L-6200 In-
telligent pump and Varian Pursuit C18 5μ column from
Hitachi with DataAce workstation to detect the presence
of bixin. The working standard concentration was 1mg
of bixin (96.5% purity by HPLC; Source: Chromadex,
Inc) in 1ml of 1:1 dichloromethane: methanol. The dried
methanol extract of C. pictus leaves was dissolved in the
concentration of 1mg in 1ml of 1:1 dichloromethane:
methanol. The solvent system containing 0.1% Trifluor-
oacetic acid in HPLC water as A and acetonitrile as gra-
dient elution of 50-90% of B over 10 minutes and held
at 90% B for 4 minutes was used as the mobile phase
and the flow rate was maintained at 5.0 ml/min at a
wavelength of 444 nm. The sample was filtered through
sodium sulphate and C18 cartridges, after which 10μl
sample was injected and calibration curve for bixin was
generated.Additional files
Additional file 1: Venn diagram depicting sharing of transcripts
annotated by six different databases. The Venn diagram shows
transcripts unique to each database and which are shared amongst
different databases.
Additional file 2: PlantCyc Enzyme Annotations. The tab delimited
table lists the pathway annotations from PlantCyc enzymes annotation.
Additional file 3: Other Secondary Metabolite Annotations. The
document shows the percentage distribution of other secondary
metabolite pathway related transcripts observed from PlantCyc enzymes
annotation.
Additional file 4: Swiss-Prot Annotations. The tab delimited table lists
the Swiss-Prot annotations leading to Gene Ontology term classifications.
Additional file 5: KOG Annotations. The tab delimited table lists the
annotations from Cluster of Orthologous Groups leading to KOG
classifications.
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annotations from Pfam protein domains.
Additional file 7: Final Annotation table. The final tab delimited table
lists the best annotation assigned to transcripts after picking the best
annotation from individual databases.
Additional file 8: SNPs. The tab delimited table lists the SNPs obtained
after aligning the reads back to the transcripts.
Additional file 9: Supplementary data for Validation of assembled
transcripts of C. pictus.
Additional file 10: SSRs. The tab delimited table lists the SSRs
identified using MISA.
Additional file 11: Similarity search among other anti-diabetic plant
resources. The file provides results of similarity search of the transcripts
against GenBank nucleotide sequences from other anti-diabetic plants.
Additional file 12: SNP filtering criteria. The file provides criteria used
for filtering SNPs.
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